| Scale |
Time period |
Experimental group (n=8) |
Control group (n=8) |
| Mean±SD |
F |
p-value |
Mean±SD |
F |
p-value |
| WMFT |
Baseline |
2.68±0.71 |
4.32 |
0.069 |
2.68±0.71 |
4.32 |
0.069 |
| 2 weeks |
3.33±0.94 |
3.33±0.94 |
| 4 weeks |
3.83±1.1 |
3.83±1.13 |
| MAL (AOU) |
Baseline |
2.60±0.73 |
7.26 |
0.025* |
2.44±0.64 |
3.19 |
0.11 |
| |
2 weeks |
3.39±0.82 |
3.05±0.92 |
| |
4 weeks |
3.84±0.95 |
3.43±1.29 |
| MAL (QOU) |
Baseline |
2.60±0.73 |
7.26 |
0.025* |
2.44±0.64 |
3.19 |
0.11 |
| |
2 weeks |
3.39±0.82 |
|
|
3.05±0.92 |
|
|
| |
4 weeks |
3.84±0.95 |
|
|
3.43±1.29 |
|
|
*=significant at p< 0.05. |
